IHS Chemical Week

Regions :: Australia/New Zealand

DSM signs biologics development and manufacturing agreement with Australian firm

4:53 AM MDT | October 30, 2012 | Deepti Ramesh

DSM Pharmaceutical Products (Parsippany, NJ), the business unit of DSM which provides contract manufacturing and development services to the pharma and biopharma industries, says it has signed a biologics contract manufacturing agreement with Paranta Biosciences (Melbourne). Financial terms were not disclosed. Paranta Biosciences is an early stage drug development company that develops and commercializes biotherapeutics based on recombinant human follistatin for the treatment of respiratory diseases. The contract covers the process development and manufacture by...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa